Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Psoriatic arthritis.

Dafna D Gladman1

  • 1Center for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario. dafna.gladman@utoronto.ca

Dermatologic Therapy
|September 24, 2004
PubMed
Summary
This summary is machine-generated.

Psoriatic arthritis, a form of inflammatory arthritis linked to psoriasis, causes significant disability and mortality. Emerging biologic treatments show promise in controlling inflammation and preventing joint damage progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement properties of radiographic outcome measures in Psoriatic Arthritis: A systematic review from the GRAPPA-OMERACT initiative.

Seminars in arthritis and rheumatism·2021
Same author

Prologue: 2020 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).

The Journal of rheumatology·2021
Same author

European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance.

Annals of the rheumatic diseases·2021
Same author

Incidence of and Risk Factors for Heart Failure in Patients With Psoriatic Disease: A Cohort Study.

Arthritis care & research·2021
Same author

Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort.

Rheumatology (Oxford, England)·2021
Same author

Systematic literature review of non-topical treatments for early, untreated (systemic therapy naïve) psoriatic disease: a GRAPPA initiative.

Rheumatology advances in practice·2021
Same journal

Increased Risk of Cutaneous T-Cell Lymphoma Development after Dupilumab Use for Atopic Dermatitis.

Dermatologic therapy·2024
Same journal

Correction to "Adjuvant PD-1 inhibitor versus high-dose interferon α-2b for Chinese patients with cutaneous and acral melanoma: A retrospective cohort analysis".

Dermatologic therapy·2022
Same journal

A case of erythema nodosum concomitant with ulcerative colitis relieved by tofacitinib.

Dermatologic therapy·2022
Same journal

A case report of vitiligo following toripalimab therapy for a patient with metastatic melanoma.

Dermatologic therapy·2022
Same journal

High versus low dose oral isotretinoin in the treatment of cutaneous and genital warts.

Dermatologic therapy·2022
Same journal

Evaluation of the efficacy and relapse rates of treatment protocols for moderate acne using isotretinoin based on the global acne grading system: Randomized, controlled, comparative study.

Dermatologic therapy·2022
See all related articles

Area of Science:

  • Rheumatology
  • Dermatology
  • Immunology

Background:

  • Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis.
  • Historically, PsA has been considered uncommon due to a lack of diagnostic criteria.
  • PsA is increasingly recognized for its potential to cause severe disability and increase mortality.

Purpose of the Study:

  • To highlight the unique features of psoriatic arthritis.
  • To discuss the limitations of traditional treatments.
  • To introduce the potential of new biologic therapies.

Main Methods:

  • Review of epidemiological and clinical studies.
  • Analysis of disease progression and mortality data.
  • Evaluation of treatment outcomes for traditional and biologic medications.

Related Experiment Videos

Main Results:

  • Epidemiological and clinical evidence supports PsA as a distinct inflammatory condition.
  • Traditional medications have shown limited efficacy in halting joint damage progression.
  • Biologic therapies demonstrate potential for controlling inflammation and preventing joint damage.

Conclusions:

  • Psoriatic arthritis is a significant condition with unique characteristics.
  • Effective management strategies are evolving with the advent of biologic treatments.
  • Further research is needed to optimize PsA treatment and improve patient outcomes.